Researchers for the massive Dual Anti-platelet Therapy Study found that patients receiving drug-eluting stents had a lower rate of stent thrombosis and other major cardiovascular events than those treated with bare-metal stents, undermining the common perception that bare-metal stents are safer.
The data, which was the focus of a secondary DAPT analysis, was presented by co-principal investigator Dr. Dean Kereiakes last week at the American Heart Assn.'s annual meeting.
Help employers find you! Check out all the jobs and post your resume.
